Copy
View this email in your browser
Dear Reader,

Mike's Blog - January 2020

New Working Groups Addressing Translational Science Issues
In 2019 we released a new Guidance for CTSA Program Groups to enhance and promote communication and collaboration at all levels throughout the CTSA Consortium. The guidance included information on our new Working Groups, which will address, optimize and/or improve thorny issues in translational science in innovative and efficient ways. Through collaboration and sharing of ideas and expertise, Working Groups are tasked to develop innovative approaches to common and less ‘wicked’ problems that are encountered (or will be encountered) in translational science and its application towards new therapies/approaches. Their activities, findings and deliverables should also contribute to the CTSA knowledge base, thus allowing us to share experiences with others within the Consortium and beyond. Continue Reading

THE SPOTLIGHT


Now Accepting Applications for Second Cycle (Cycle II) of the 2020 CTSA Program Working Groups

The CTSA Program Steering Committee is now accepting the second round (Cycle II) of proposals for 2020 Working Groups. As a reminder the Guidance for CTSA Program Groups states “A maximum of 12 active WGs will be supported by the CTSA Program Coordinating Center across the consortium at any given time with a target of ≤ 2 from a specific EC". If you wish to submit a CTSA Program Working Group proposal that is to be associated with an Enterprise Committee, please make sure that it is approved by the EC Lead Team prior to submission. To submit a proposal, please log on to the CLIC website and complete this form. Groups or individuals interested in forming a Working Group are required to propose and deliver well-defined projects or deliverables that fill identified translational gaps and/or further the CTSA Program objectives in high priority areas within clinical and translational science. 

Any group or individual within the CTSA Program is eligible to submit an application for a Working Group. Working Groups that are approved by the CTSA Program Steering Committee will be supported by CLIC. The deadline to submit a 2020 Cycle II CTSA Working Group proposal is Friday, Jan. 31, 2019.


WHAT'S NEW


Registration is Now Open for the 2020 Spring CTSA Program Group Meetings

Register now for the Spring CTSA Program Meeting to be held April 14, 2020 - April 15, 2020, at the Marriott Wardman Park Hotel in Washington, DC. The Spring CTSA Program Group Meeting supports meetings of several Enterprise Committees (EC) and Consortium groups.

In-person Registration Deadline: March 27, 2020
Zoom Registration Request Deadline: April 3, 2020

Registration is required whether attending in-person or via Zoom.

Note: With the timing of this year’s meeting near the spring holidays, please be aware that there will be overlap with some of the ACTS programming. CLIC, NCATS, and ACTS have worked collaboratively to minimize content session overlap as much as possible.

If you have questions or need further information, please contact the CLIC Meeting Planner at program_meetings@clic-ctsa.org 

Registration is Open for the Lifespan, Life Course Research Un-Meeting

Northwestern University’s Clinical and Translational Science Institute (NUCATS) is hosting the 2020 CLIC supported Un-Meeting focusing on Lifespan and Life Course Research: Integrating Strategies. Participants will meet to Explore, enhance and disseminate strategies for lifespan and life course research study design; enhance recruitment, enrollment and retention across the lifespan through partnerships; share ideas and promote new collaborations. The event begins with a welcome reception on Sunday, March 1, followed by an Un-Meeting on Monday, March 2.

Visit the event website to register and learn more, including details about travel stipends available for CTSA Program hub nominees. There is no cost to register.

New Prior Approval Request Central Mailbox for non-Human Subjects Research Prior Approval Requests and Updates to the Human Subjects Research Prior Approval Instructions

NCATS has created a new prior approval request central mailbox to be used for prior approval requests, including changes in key personnel, extensions, vertebrate animals, and unobligated funds/carryover.  The detailed guidance on the submission requirements for the most common NIH prior approval requests can be accessed here. For prior approval submissions for Live Vertebrate Animals follow the corresponding guidance. All above prior approval requests must be submitted in writing (including submission by email) to the central mailbox: NCATSPriorApprovalRequest@mail.nih.gov with a copy to the named Grants Management Specialist (GMS) and Program Officer (PO) no later than 30 days before the proposed change and signed by the Authorized Organizational Representative. As a point of clarification, please DO NOT submit Human Subjects Research Prior Approval (HSRPA) requests packages through the new prior approval central mailbox as these requests must continue to be submitted through the eRA HSS system. Also, updates have been made to the HSRPA Request Addendum & Instructions for PIs and SOs and the changes made are highlighted in the document. (version4) For additional questions about prior approval requests please follow the links provided above or contact your Grants Management Specialist and/or assigned Program Official.

Notice of Special Interest (NOSI): Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (NOT-OD-20-022 and NOT-OD-20-024)

NIH is issuing this NOT-OD-20-022 to expand the community of investigators conducting research related to Down Syndrome(DS) by encouraging CTSAs to recruit scientists and physicians early in their research careers to develop research projects related to co-occurring conditions associated with DS. This NOSI will support additional scholar slots to those KL2 grants currently approved under the CTSA Program. In addition NIH also issued NOT-OD-20-024 to support administrative supplements of CTSA UL1 awards. NCATS Funding Priorities are available on the INCLUDE website. Applications in response to this NOSI should be aligned with the overall INCLUDE Project Research Plan. For more information, including NCATS Point of Contact, follow the above links to these notices.

 

Notice of Special Interest (NOSI): Availability of Administrative and Revision Supplements to Expand Vaping Research and Understand EVALI (NOT-HL-19-724)

This Notice of Special Interest (NOSI) calls for research on the causes, disease mechanisms, and long-term prognosis of individuals with electronic cigarette (e-cigarette), or vaping associated lung injury (EVALI) and related health effects of vaping. Participating Institutes and Centers announce the availability of funds for Administrative Supplements and Competitive Revisions to active funded grants to investigate research questions relevant to EVALI. For more information about this notice, including the NCATS point of contact.

Notice of Special Interest (NOSI): Administrative Supplement for Research on Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-20-038)

The NIH Office of Science Policy (OSP) within the Office of the Director (OD) announces the availability of administrative supplements to support research on bioethical issues to develop an evidence base that may inform future policy directions. Applicants may propose to supplement parent awards focused on bioethics or to add a component related to bioethics to a parent award in which bioethics was not the focus. Note that applications must be within the general scope of the parent award. For more information about this notice, including the NCATS point of contact

Notice of Change to Award Budget and Removal of Prior Approval Requirement for PAR-19-099 (NOT-TR-20-004)

The purpose of this notice is to update information regarding: 1) the allowable budget request in Section II; and 2) removal of prior approval requirement for requests of $500,000 or more for direct costs in any year in Section IV of PAR-19-099, “Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional).”

GET INVOLVED


View News Button
View Funding Opportunities button
View Meetings & Events Button
View Education Button
CONNECT WITH NCATS
ncats.nih.gov
NCATS Facebook NCATS Twitter NCATS Linkedin
CONNECT WITH CLIC
clic-ctsa.org
CLIC Twitter
Copyright © 2020 CLIC, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.